Recent Advances in GC, Tuesday 30th September 2025, Science and Industry Museum, Manchester
The Chromatographic Society is pleased to announce, Recent Advances in Gas Chromatography, will be held on Tuesday 30th September 2025 at the Science and Industry Museum in Manchester, UK.
The now and the next of Gas Chromatography?
This meeting will take review past developments, consider recent advances and provide a perspective into the possible future developments in Gas Chromatography. As always, the Recent Advances in GC meeting will encompass advancements in automation, new sample introduction techniques, the latest instrumentation and the developments in Artificial Intelligence to deal with difficult sample matrices, challenging separations and lower detection limits.
Link to the final agenda below.
Recent Advances in GC showcases the work from industry, academia and the instrument companies and always delivers top scientific presentations focused on GC.
Delegates: £80
Delegates with Chromsoc membership: £65
To exhibit: £650
To exhibit with 10 minute presentation: £1000
The Chromatographic (Analytical) method life cycle (2026): From cradle to grave (III)/ ChromSoc Spring Symposium: 13-14th May 26: co-organised with JPAG (RSC Burlington House, London, UK)
The Chromatographic Society and Joint Pharmaceutical Analysis Group are pleased to announce another one-day meeting in the series: “The Chromatographic (Analytical) method life cycle: From cradle to grave (III).”
Like previous meetings, it will have a full and exciting topic and speakers program one that has also been purposefully designed to facilitate delegate and exhibitor access to a wide range of scientists, many of whom are leaders in their field.
The meeting seeks to provide a clear insight into successful strategies in critical areas including the new ICHQ14 and ICH Q2 guideline updates, and other guidelines/chapter, such as the BP and JP chapters and upcoming USP<1220>, <1221> and <1225> chapters). It will cover all stages, from method development and robustness using a range of separation techniques (LC, SFC, GC, CE), qualification and validation, transfer and continuous performance monitoring. It will focus on analytical life-cycle management in the Pharmaceutical industry and the latest regulatory expectations, including AQbD and permitted chromatographic method changes according to main Pharmacopoeias.
The topics will also emphasise the holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management, key elements of the enhanced approach described in ICH Q14, including Analytical Target Profile (ATP), Knowledge Management, Analytical Risk Assessment, and Performance Monitoring, and how they are integrated into a holistic Analytical Quality by Design (AQbD) framework for analytical procedure development and lifecycle management. How to leverage a risk-based approach, and balance between the benefits of post-approval flexibility and the resource investments required for implementation of the additional elements. Where the aim is over time, that the proposed strategy should streamline analytical development, resulting in well-understood analytical methods, and simplify lifecycle management.
There will be several cases studies on how Pharma companies hope to holistically implement these advanced method development and lifecycle concepts in the context of a patient-centred approach and a risk-based control strategies. Including aligning and strengthening the link between the quality attributes of a product and an analytical procedure, and minimising the risks of future changes and impact on the overall product control strategy. The 2 day meeting will also cover predictive modelling and digital tools and how Industry needs to further strengthen the mindset and available skills in statistics.
These presentations will be delivered by highly regarded and experience international speakers from industry, regulators and the chromatography industry who will share their knowledge and experience in applying and implementing the principles of AQbD. We believe the calibre of the speakers, combined with a fully integrated exhibition and vendor presentation programme, will deliver a highly interesting and well attended event. Ultimately the meeting will provide attendees with a unique means of sharing real experiences with other professionals and will provide excellent networking opportunities. ChromSoc student bursaries are available for this event.
The meeting is designed to be a relatively low cost meeting to encourage attendance of delegates from life sciences. ChromSoc student bursaries are available for this event.
If you would like to discuss further, exhibit or present at this event please forward all requests to Adrian Clarke (adrian.clarke@novartis.com).
Q4 2026: Advances in Clinical and Forensic Analysis 2026 (1 day, London) with RSC SSG (RSC Burlington House, London, UK)
Continuation in the long series of “Advances in Clinical and forensic Analysis” meetings started in 2012, the Chromatographic Society and the Separations Science Group of the Analytical Division of the Royal Society of Chemistry are pleased to announce the following one-day meeting:
“Advances in Clinical and Forensic Analysis 2026” to be held in Q4’ 2026, at RSC Burlington House, London, UK.
Clinical and Forensic analysis are some of the most exciting and important areas in Life Sciences and the meeting will provide an insight into the latest methodologies and technological developments for clinical and forensic applications, focusing on Cannabis and Cannabinoids screening and other current hot topics and challenges. In particular the application of novel sample preparation techniques and tools, novel techniques and the wider utilisation of mass spectrometry and digital tools in clinical and forensic analysis. Clinical and Forensic analysis are wide-ranging subject areas and as we move to more complex and difficult analyses the methodologies are being challenged in terms of the specificity, sensitivity and also the suitability for high throughput and lower cost analysis.
The meeting will focus on separation and complementary/alternative techniques along with case studies from the hospital, commercial and academic areas. The program has been designed to give attendees an update for both routine and problem solving in clinical and forensic analysis.
Advances in Clinical and Forensic Analysis 2026 provides you with a unique means of sharing real experiences with other professionals and will provide excellent networking opportunities. The program is designed to give attendees a range of highly interesting topics from highly regarded speakers and new emerging professionals. As a result of the speakers we aim to recruit for this meeting and our proposed exhibition and vendor presentation programme, we believe this will be a highly interesting and well attended event.
The meeting is designed to be a relatively low cost meeting to encourage attendance of delegates from life sciences. ChromSoc student bursaries are available for this event.
If you would like to discuss further, exhibit or present at this event please forward all requests to Adrian Clarke (adrian.clarke@novartis.com).
